September 14, 2017 08:43 AM EDTUpdated September 14, 11:44 PM
R&D
Discovery

As­traZeneca and Mod­er­na take a big, ear­ly step for­ward in their quest to prove mR­NA works in hu­mans

John Carroll

Editor & Founder

Biotech uni­corn Mod­er­na has re­vamped its de­vel­op­ment struc­ture, pulled back the veil on more of its R&D work and spot­light­ed a sig­nif­i­cant clin­i­cal step for­ward …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

No­var­tis to cut 139 jobs in NJ as part of com­mer­cial re­fo­cus

Ad­vanz Phar­ma faces re­vo­ca­tion of Eu­ro­pean au­tho­riza­tion for liv­er dis­ease drug Ocali­va

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

Bris­tol My­ers sues the fed­er­al gov­ern­ment over 340B, fol­low­ing oth­er drug­mak­ers

Nor­bert Bischof­berg­er's time as Kro­nos CEO ends as biotech seeks new life

A service from the Financial Times